174 related articles for article (PubMed ID: 12944549)
21. Angiomatoid "malignant" fibrous histiocytoma: a clinicopathologic study of 158 cases and further exploration of the myoid phenotype.
Fanburg-Smith JC; Miettinen M
Hum Pathol; 1999 Nov; 30(11):1336-43. PubMed ID: 10571514
[TBL] [Abstract][Full Text] [Related]
22. Plexiform fibrohistiocytic tumour: clinicopathological, immunohistochemical and ultrastructural analysis in favour of a myofibroblastic lesion.
Hollowood K; Holley MP; Fletcher CD
Histopathology; 1991 Dec; 19(6):503-13. PubMed ID: 1723956
[TBL] [Abstract][Full Text] [Related]
23. Leiomyosarcoma with prominent osteoclast-like giant cells. Analysis of eight cases closely mimicking the so-called giant cell variant of malignant fibrous histiocytoma.
Mentzel T; Calonje E; Fletcher CD
Am J Surg Pathol; 1994 Mar; 18(3):258-65. PubMed ID: 8116793
[TBL] [Abstract][Full Text] [Related]
24. Specificity and sensitivity of differentiation antigens in superficial soft tissue tumors: comparison of SMA, calponin, H-caldesmon, C-kit, PLAP and HPL.
Durak H; Comunoglu NU; Comunoglu C; Guven A; Cam M; Dervisoglu S; Eren B
Bratisl Lek Listy; 2010; 111(8):432-8. PubMed ID: 21033622
[TBL] [Abstract][Full Text] [Related]
25. Malignant peripheral nerve sheath tumors and spindle cell sarcomas: an immunohistochemical analysis of multiple markers.
Giangaspero F; Fratamico FC; Ceccarelli C; Brisigotti M
Appl Pathol; 1989; 7(2):134-44. PubMed ID: 2471540
[TBL] [Abstract][Full Text] [Related]
26. Reassessment and clinicopathological prognostic factors of malignant fibrous histiocytoma of soft parts.
Oda Y; Tamiya S; Oshiro Y; Hachitanda Y; Kinukawa N; Iwamoto Y; Tsuneyoshi M
Pathol Int; 2002 Sep; 52(9):595-606. PubMed ID: 12406189
[TBL] [Abstract][Full Text] [Related]
27. Characterization of human soft tissue sarcomas in nude mice. Evidence for histogenic properties of malignant fibrous histiocytomas.
Roholl PJ; Rutgers DH; Rademakers LH; De Weger RA; Elbers JR; Van Unnik JA
Am J Pathol; 1988 Jun; 131(3):559-68. PubMed ID: 2837905
[TBL] [Abstract][Full Text] [Related]
28. Malignant fibrous histiocytomas in dogs and cats: an immunohistochemical study.
Thoolen RJ; Vos JH; van der Linde-Sipman JS; de Weger RA; van Unnik JA; Misdorp W; van Dijk JE
Res Vet Sci; 1992 Sep; 53(2):198-204. PubMed ID: 1332152
[TBL] [Abstract][Full Text] [Related]
29. Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma.
Fletcher CD
Am J Surg Pathol; 1992 Mar; 16(3):213-28. PubMed ID: 1317996
[TBL] [Abstract][Full Text] [Related]
30. [Immunohistochemical differentiation of leiomyocellular tumors and tumors with myogenic differentiation].
Povýsil C; Ciprová V; Dundr P; Horáková M
Cesk Patol; 2003 Apr; 39(2):64-8. PubMed ID: 12874903
[TBL] [Abstract][Full Text] [Related]
31. Calponin and h-caldesmon expression in atypical fibroxanthoma and superficial leiomyosarcoma.
Sakamoto A; Oda Y; Yamamoto H; Oshiro Y; Miyajima K; Itakura E; Tamiya S; Honda Y; Ishihara A; Iwamoto Y; Tsuneyoshi M
Virchows Arch; 2002 Apr; 440(4):404-9. PubMed ID: 11956822
[TBL] [Abstract][Full Text] [Related]
32. Antibody specific to muscle actins in the diagnosis and classification of soft tissue tumors.
Miettinen M
Am J Pathol; 1988 Jan; 130(1):205-15. PubMed ID: 3276210
[TBL] [Abstract][Full Text] [Related]
33. Transgelin is a novel marker of smooth muscle differentiation that improves diagnostic accuracy of leiomyosarcomas: a comparative immunohistochemical reappraisal of myogenic markers in 900 soft tissue tumors.
Robin YM; Penel N; Pérot G; Neuville A; Vélasco V; Ranchère-Vince D; Terrier P; Coindre JM
Mod Pathol; 2013 Apr; 26(4):502-10. PubMed ID: 23174934
[TBL] [Abstract][Full Text] [Related]
34. Expression of insulin-like growth factor 1 in sarcomas.
Roholl PJ; Skottner A; Prinsen I; Lips CJ; Den Otter W; Van Unnik JA
Histopathology; 1990 May; 16(5):455-60. PubMed ID: 2163355
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemistry of markers of histiomonocytic cells in malignant fibrous histiocytomas. A monoclonal antibody study.
Soini Y; Miettinen M
Pathol Res Pract; 1990 Dec; 186(6):759-67. PubMed ID: 1964732
[TBL] [Abstract][Full Text] [Related]
36. Malignant fibrous histiocytoma: morphologic pattern or pathologic entity?
Hollowood K; Fletcher CD
Semin Diagn Pathol; 1995 Aug; 12(3):210-20. PubMed ID: 8545588
[TBL] [Abstract][Full Text] [Related]
37. h-Caldesmon in leiomyosarcoma and tumors with smooth muscle cell-like differentiation: its specific expression in the smooth muscle cell tumor.
Watanabe K; Kusakabe T; Hoshi N; Saito A; Suzuki T
Hum Pathol; 1999 Apr; 30(4):392-6. PubMed ID: 10208459
[TBL] [Abstract][Full Text] [Related]
38. [Reassessment of the pathological diagnosis in 33 cases of malignant fibrous histiocytoma].
Guo H; Xiong Y; Nong L; Zhang S; Li T
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):374-9. PubMed ID: 18677383
[TBL] [Abstract][Full Text] [Related]
39. Progressive loss of myogenic differentiation in leiomyosarcoma has prognostic value.
Demicco EG; Boland GM; Brewer Savannah KJ; Lusby K; Young ED; Ingram D; Watson KL; Bailey M; Guo X; Hornick JL; van de Rijn M; Wang WL; Torres KE; Lev D; Lazar AJ
Histopathology; 2015 Apr; 66(5):627-38. PubMed ID: 24889065
[TBL] [Abstract][Full Text] [Related]
40. Epithelioid leiomyosarcoma of the skin and subcutaneous tissue. Clinicopathologic, immunohistochemical, and ultrastructural study of five cases.
Suster S
Am J Surg Pathol; 1994 Mar; 18(3):232-40. PubMed ID: 8116792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
